AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Worldwide Meningitis Vaccines Market Outlook, 2027 with Sanofi Pasteur, GSK, Pfizer, Merck, and Essilor Dominating - ResearchAndMarkets.com

May 3, 2019

DUBLIN--(BUSINESS WIRE)--May 3, 2019--The “Meningitis Vaccines Market” report has been added to ResearchAndMarkets.com’s offering.

The global market of meningitis vaccine stood at USD 12,783.1 Million in 2018 and is expected to reach USD 27,522.5 Million by the end of 2027, expanding at a CAGR of 8.9% over the forecast period i.e. 2019-2027. The advancements in meningitis vaccine and growing healthcare sector globally is anticipated to further boost the demand for meningitis vaccine in future.

Geographically, North America accounted for the largest market share of 41.2% in 2018 in the revenue of meningitis vaccine market globally. The market of North America region is expected to continue its dominance over the forecast period on the back of rising demand for efficient disease preventive Vaccine across the region.

Robust research and development are going on in healthcare sector to manufacture advanced and cost-effective meningitis Vaccine. The advanced meningitis vaccine further provides precise and accurate dosing with minimalist side effects to the vaccinated population.

The adoption of advanced and high end Vaccine is rising in developing regions such as India, China, Japan and others. To gain a competitive edge, different manufacturers of medical equipment have come up with various new Vaccine to effectively aid in the prevention of meningitis.

With USD 5,999.9 Million revenue by the end of 2027 in the global market, Asia-Pacific Meningitis Vaccine market is expected to showcase lucrative growth over the forecast period. This growth is primarily attributed on the back of increasing governing regulatory body initiatives in order to reduce the number of deaths caused to meningitis across the region.

With the increasing focus of people on healthcare, the Asia-Pacific meningitis vaccine market is expected to witness rapid growth throughout the forecast period. Asia-Pacific market is expected to expand at a CAGR of 9.4% over the forecast period and expected to contribute a market share of 21.8% in global meningitis vaccine market.

Additionally, favorable government initiatives to develop the healthcare infrastructure coupled with increasing healthcare expenditure across the globe is envisioned to bolster the growth of the meningitis Vaccine market robustly over the forecast period.

Moreover, Europe is estimated to grow at a CAGR of 8.7% over the forecast period contributing a market share of 25.6% in the year 2027 in the global meningitis market.

Some of the leading manufacturers in this market are Sanofi Pasteur, GSK, Pfizer, Merck and Essilor among others.

Key Topics Covered

1. Introduction

1.1. Market Definition

1.2. Product Overview

1.3. Market Segmentation

1.4. Features by Popular Products Available

2. Assumptions and Acronyms

3. Research Methodology

4. Executive Summary- Global Meningitis Vaccine Market

5. Market Dynamics

5.1. Drivers

5.2. Restraints

5.3. Trends

5.4. Opportunities

6. Risk Analysis

6.1. Demand Risk

6.2. Supply Risk

7. Global Meningitis Vaccine Market Outlook

7.1. Market Size and Forecast, 2018-2027

7.1.1. By Value (USD Million)

7.1.1.1. Y-o-Y Growth (%), 2019-2027

7.2. Market Share and Forecast, 2018-2027

7.2.1. By Vaccine

7.2.1.1. Meningitis Vaccine Market Share (%), By Vaccine (2018, 2027F)

7.2.1.1.1. Meningococcal Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

7.2.1.1.1.1. MenB, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

7.2.1.1.1.2. MenC, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

7.2.1.1.1.3. MenACWY, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

7.2.1.1.2. Pneumococcal vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

7.2.1.1.2.1. PCV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

7.2.1.1.2.2. PPV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

7.2.1.1.3. Hib, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

7.2.1.2. Market Attractiveness Analysis, By Vaccine

7.2.1.3. Market Contribution and BPS Analysis, 2018 & 2027, By Vaccine

7.2.2. By Composition

7.2.2.1. Meningitis Vaccine Market Share (%), By Composition (2018, 2027F)

7.2.2.1.1. Polysaccharide Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

7.2.2.1.2. Conjugate Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

7.2.2.1.3. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

7.2.2.2. Market Attractiveness Analysis, By Composition

7.2.2.3. Market Contribution and BPS Analysis, 2018 & 2027, By Composition

7.2.3. By End User

7.2.3.1. Meningitis Vaccine Market Share (%), By End User (2018, 2027F)

7.2.3.1.1. Hospitals, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

7.2.3.1.2. Clinics, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

7.2.3.1.3. Ambulatory Surgical centers, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

7.2.3.1.4. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

7.2.3.2. Market Attractiveness Analysis, By End User

7.2.3.3. Market Contribution and BPS Analysis, 2018 & 2027, By End User

7.2.4. By Region

7.2.4.1. Meningitis Vaccine Market Share (%), By Region (2018,2027F)

7.2.4.1.1. North America

7.2.4.1.2. Europe

7.2.4.1.3. Asia Pacific

7.2.4.1.4. Latin America

7.2.4.1.5. Middle East and Africa

8. North America Meningitis Vaccine Market Outlook

9. Europe Meningitis Vaccine Market Outlook

10. Asia Pacific Meningitis Vaccine Market Outlook

11. Latin America Meningitis Vaccine Market Outlook

12. Middle East and Africa Meningitis Vaccine Market Outlook

13. Competitive Landscape

13.1. Competitive Positioning of Major Players in Global Meningitis Vaccine Market

13.2. Company Profiles

13.2.1. GlaxoSmithKline plc

13.2.1.1. Company Overview

13.2.1.2. Business Strategy

13.2.1.2.1. Growth Expansion Strategy

13.2.1.2.2. Distribution Channel Strategy

13.2.1.2.3. Product Strategy

13.2.1.3. Key Product Offerings

13.2.1.4. Financial Performance

13.2.1.5. Key Performance Indicators

13.2.1.6. Risk Analysis

13.2.1.7. Recent Development

13.2.1.8. Regional Presence

13.2.1.9. SWOT Analysis

13.2.2. Pfizer Inc.

13.2.3. Sanofi Pasteur SA

13.2.4. Merck & Co., Inc.

13.2.5. Janssen

13.2.6. Panacea

13.2.7. Hualan Biological Engineering Inc.

13.2.8. Serum Institute of India Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/1on0fi

View source version on businesswire.com:https://www.businesswire.com/news/home/20190503005224/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Vaccines

KEYWORD:

INDUSTRY KEYWORD: HEALTH INFECTIOUS DISEASES PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2019.

PUB: 05/03/2019 07:48 AM/DISC: 05/03/2019 07:48 AM

http://www.businesswire.com/news/home/20190503005224/en